Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypoglycemia and insulin treatment.

× No keyword cloud information.

17 in total

1. Insulin glargine.

Authors: G B Bolli; D R Owens
Journal: Lancet Date: 2000-08-05 Impact factor: 79.321

Review 2. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine.

Authors: P D Home; A Fritsche; S Schinzel; M Massi-Benedetti
Journal: Diabetes Obes Metab Date: 2010-09 Impact factor: 6.577

3. Insulin detemir: A historical perspective on a modern basal insulin analogue.

Authors: Luigi Meneghini; Andreas Liebl; Martin J Abrahamson
Journal: Prim Care Diabetes Date: 2010-04 Impact factor: 2.459

4. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

Authors: Athena Philis-Tsimikas; Guillaume Charpentier; Per Clauson; Gabriela Martinez Ravn; Victor Lawrence Roberts; Birger Thorsteinsson
Journal: Clin Ther Date: 2006-10 Impact factor: 3.393

5. A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

Authors: Sanne G Swinnen; Marie-Paule Dain; Ronnie Aronson; Melanie Davies; Hertzel C Gerstein; Andreas F Pfeiffer; Frank J Snoek; J Hans Devries; Joost B Hoekstra; Frits Holleman
Journal: Diabetes Care Date: 2010-03-03 Impact factor: 17.152

6. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors: Matthew C Riddle; Julio Rosenstock; John Gerich
Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112

7. Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.

Authors: Alan J Garber; Per Clauson; Claus B Pedersen; Klaus Kølendorf
Journal: J Am Geriatr Soc Date: 2007-11 Impact factor: 5.562

Review 8. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Authors: K Horvath; K Jeitler; A Berghold; S H Ebrahim; T W Gratzer; J Plank; T Kaiser; T R Pieber; A Siebenhofer
Journal: Cochrane Database Syst Rev Date: 2007-04-18

9. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Authors: Tim Heise; Leszek Nosek; Birgitte Biilmann Rønn; Lars Endahl; Lutz Heinemann; Christoph Kapitza; Eberhard Draeger
Journal: Diabetes Date: 2004-06 Impact factor: 9.461

10. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.

Authors: Stephen S Johnston; Christopher Conner; Mark Aagren; David M Smith; Jonathan Bouchard; Jason Brett
Journal: Diabetes Care Date: 2011-03-18 Impact factor: 19.112

2 in total

1. Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes.

Authors: Javier Íbias; Laura E O'Dell; Arbi Nazarian
Journal: Behav Brain Res Date: 2018-05-24 Impact factor: 3.332

2. Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.

Authors: Bryan Cruz; Rodolfo J Flores; Kevin P Uribe; Evangelina J Espinoza; Charles T Spencer; Katherine M Serafine; Arbi Nazarian; Laura E O'Dell
Journal: Neuropsychopharmacology Date: 2019-01-07 Impact factor: 7.853

2 in total